Clinical Trial Supply and Logistics Market for Pharma 2023-2033

Clinical Trial Supply and Logistics Market for Pharma 2023-2033



The Clinical Trial Supply and Logistics for Pharma Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Digitization, Personalized Medicine, and Globalization Reshaping Clinical Trials Supply Logistics Landscape

The landscape of clinical trial supply logistics in the pharmaceutical industry is undergoing a significant transformation. The trends towards digitization, personalized medicine, and globalization are reshaping how companies approach the management and distribution of investigational products. While regulatory compliance and patient-centricity remain paramount, the industry is presented with opportunities to leverage advanced technologies for more agile and efficient supply chain operations. Overcoming challenges associated with supply chain complexity, unforeseen events, and cost pressures will be critical for companies seeking to navigate this evolving landscape successfully. By embracing these trends and seizing the associated opportunities, pharmaceutical companies can optimize their clinical trial supply chains to deliver innovative therapies to patients more efficiently than ever before.

3D Printing and On-Demand Manufacturing

The advent of 3D printing technology opens up a new frontier in clinical trial supply logistics. It offers the potential to revolutionize the manufacturing and production of investigational products. 3D printing allows for on-demand, localized production of certain medical devices, dosage forms, and even personalized treatments.

This opportunity is particularly significant for trials involving specialized or niche patient populations. Rather than relying on centralized manufacturing facilities and extensive lead times, pharmaceutical companies can use 3D printing to produce customized investigational products closer to the trial sites. This not only reduces transportation and logistics complexities but also enables a more patient-centric approach to clinical trials.

Furthermore, 3D printing can facilitate rapid prototyping and iteration of medical devices, allowing for the development of more effective and tailored solutions. This technology empowers researchers to quickly adapt and refine their products based on real-world feedback from clinical trials, ultimately leading to more innovative and impactful therapies.

What Questions Should You Ask before Buying a Market Research Report?
  • How is the clinical trial supply and logistics for pharma market evolving?
  • What is driving and restraining the clinical trial supply and logistics for pharma market?
  • How will each clinical trial supply and logistics for pharma submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each clinical trial supply and logistics for pharma submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading clinical trial supply and logistics for pharma markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the clinical trial supply and logistics for pharma projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of
clinical trial supply and logistics for pharma projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the clinical trial supply and logistics for pharma market?
  • Where is the clinical trial supply and logistics for pharma market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the clinical trial supply and logistics for pharma market today, and over the next 10 years:
  • Our 258-page report provides 107 tables and 123 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them – NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the clinical trial supply and logistics for pharma market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Type
  • CTS Manufacturing
  • CTS Logistics & Distribution
  • CT Supply Chain Management
  • CTS Packaging & Storage
Phase
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Post Launch
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:

North America
  • U.S.
  • Canada
Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • South-East Asia
  • Rest of Asia Pacific
Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
MEA
  • GCC
  • South Africa
  • Rest of MEA
The report also includes profiles and for some of the leading companies in the Clinical Trial Supply and Logistics for Pharma Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies profiled in the report
  • Almac Group
  • Bilcare Limited
  • Biocair
  • Capsugel
  • Catalent, Inc.
  • Eurofins Scientific
  • FedEx
  • ICON plc
  • Intertek Group plc
  • KERRY LOGISTICS NETWORK LIMITED
  • Kuehne+Nagel
  • Marken (A UPS Company)
  • Mayne Pharma Group Limited
  • Movianto
  • Parexel International (MA) Corporation
  • PCI Pharma Services (PCI)
  • Thermo Fisher Scientific Inc.
  • United Parcel Service, Inc.
  • Yourway
Overall world revenue for Clinical Trial Supply and Logistics for Pharma Market, 2023 to 2033 in terms of value the market will surpass US$13 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Clinical Trial Supply and Logistics for Pharma Market, 2023 to 2033 report help you?

In summary, our 250+ page report provides you with the following knowledge:
  • Revenue forecasts to 2033 for Clinical Trial Supply and Logistics for Pharma Market 2023 to 2033, with forecasts for type and phase, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 22 key national markets See forecasts for the Clinical Trial Supply and Logistics for Pharma Market, 2023 to 2033 market in North America, Europe, Asia Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market – including company profiles for 19 of the major companies involved in the Clinical Trial Supply and Logistics for Pharma Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Clinical Trial Supply and Logistics for Pharma Market 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher..

The publisher is using a password system to access single user and team licenses. Single user (non-printable) and team licenses expire after 12 month period. In the case of team license purchases, the publisher requires all email addresses for the licensed users prior to fulfilment.


1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Clinical Trial Supply and Logistics for Pharma Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Move Towards Decentralized/Virtual Trials
3.2.1.2 Increasing Possibilities for Conducting Clinical Trials in Asia Pacific Nations
3.2.1.3 Growing Clinical Trials Volume
3.2.2 Market Restraining Factors
3.2.2.1 Clinical Trial and Medical Cold Chain Logistics
3.2.2.2 Man-made or Natural Disruption in Transportation
3.2.2.3 High Financial Cost
3.2.3 Market Opportunities
3.2.3.1 AI and Machine Learning are Evolving with More Data
3.2.3.2 Virtual Trials and Technology Are Gaining Acceptance among Patients and Sites
3.2.3.3 Big Companies are driving the Market
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Clinical Trial Supply and Logistics for Pharma Market Analysis by Type
4.1 Key Findings
4.2 Type Segment: Market Attractiveness Index
4.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
4.4 CTS Manufacturing
4.4.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 CTS Logistics & Distribution
4.5.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.6 CT Supply Chain Management
4.6.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 CTS Packaging & Storage
4.7.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
4.7.2 Market Share by Region, 2023 & 2033 (%)
5 Clinical Trial Supply and Logistics for Pharma Market Analysis by Phase
5.1 Key Findings
5.2 Phase Segment: Market Attractiveness Index
5.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
5.4 Preclinical
5.4.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Phase I
5.5.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Phase II
5.6.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Phase III
5.7.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Phase IV
5.8.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
5.8.2 Market Share by Region, 2023 & 2033 (%)
5.9 Post Launch
5.9.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
5.9.2 Market Share by Region, 2023 & 2033 (%)
6 Clinical Trial Supply and Logistics for Pharma Market Analysis by Region
6.1 Key Findings
6.2 Regional Market Size Estimation and Forecast
7 North America Clinical Trial Supply and Logistics for Pharma Market Analysis
7.1 Key Findings
7.2 North America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
7.3 North America Clinical Trial Supply and Logistics for Pharma Market by Country, 2023, 2028 & 2033 (US$ Billion)
7.4 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
7.5 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
7.6 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
7.7 U.S. Clinical Trial Supply and Logistics for Pharma Market Analysis
7.8 Canada Clinical Trial Supply and Logistics for Pharma Market Analysis
8 Europe Clinical Trial Supply and Logistics for Pharma Market Analysis
8.1 Key Findings
8.2 Europe Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
8.3 Europe Clinical Trial Supply and Logistics for Pharma Market by Country, 2023, 2028 & 2033 (US$ Billion)
8.4 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
8.5 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
8.6 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
8.7 Germany Clinical Trial Supply and Logistics for Pharma Market Analysis
8.8 UK Clinical Trial Supply and Logistics for Pharma Market Analysis
8.9 France Clinical Trial Supply and Logistics for Pharma Market Analysis
8.10 Italy Clinical Trial Supply and Logistics for Pharma Market Analysis
8.11 Spain Clinical Trial Supply and Logistics for Pharma Market Analysis
8.12 Russia Clinical Trial Supply and Logistics for Pharma Market Analysis
8.13 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Analysis
9 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Analysis
9.1 Key Findings
9.2 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
9.3 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market by Country, 2023, 2028 & 2033 (US$ Billion)
9.4 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
9.5 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
9.6 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
9.7 Japan Clinical Trial Supply and Logistics for Pharma Market Analysis
9.8 China Clinical Trial Supply and Logistics for Pharma Market Analysis
9.9 India Clinical Trial Supply and Logistics for Pharma Market Analysis
9.10 Australia Clinical Trial Supply and Logistics for Pharma Market Analysis
9.11 South Korea Clinical Trial Supply and Logistics for Pharma Market Analysis
9.12 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Analysis
9.13 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Analysis
10 Latin America Clinical Trial Supply and Logistics for Pharma Market Analysis
10.1 Key Findings
10.2 Latin America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
10.3 Latin America Clinical Trial Supply and Logistics for Pharma Market by Country, 2023, 2028 & 2033 (US$ Billion)
10.4 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
10.5 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
10.6 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
10.7 Brazil Clinical Trial Supply and Logistics for Pharma Market Analysis
10.8 Mexico Clinical Trial Supply and Logistics for Pharma Market Analysis
10.9 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Analysis
11 MEA Clinical Trial Supply and Logistics for Pharma Market Analysis
11.1 Key Findings
11.2 MEA Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
11.3 MEA Clinical Trial Supply and Logistics for Pharma Market by Country, 2023, 2028 & 2033 (US$ Billion)
11.4 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
11.5 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
11.6 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
11.7 GCC Clinical Trial Supply and Logistics for Pharma Market Analysis
11.8 South Africa Clinical Trial Supply and Logistics for Pharma Market Analysis
11.9 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Analysis
12 Company Profiles
12.1 Catalent, Inc.
12.1.1 Company Snapshot
12.1.2 Company Overview
12.1.3 Financial Analysis
12.1.3.1 Net Revenue, 2018-2022
12.1.3.2 Regional Market Shares, 2022
12.1.4 Product Benchmarking
12.1.5 Strategic Outlook
12.2 Thermo Fisher Scientific Inc.
12.2.1 Company Snapshot
12.2.2 Company Overview
12.2.3 Financial Analysis
12.2.3.1 Net Revenue, 2018-2022
12.2.3.2 R&D, 2015-2022
12.2.3.3 Regional Market Shares, 2022
12.2.4 Product Benchmarking
12.2.5 Strategic Outlook
12.2.6 Strategic Outlook
12.3 ICON plc
12.3.1 Company Snapshot
12.3.2 Company Overview
12.3.3 Financial Analysis
12.3.3.1 Revenue, 2018-2022
12.3.3.2 Regional Market Shares, 2022
12.3.4 Product Benchmarking
12.3.5 Strategic Outlook
12.4 Eurofins Scientific
12.4.1 Company Snapshot
12.4.2 Company Overview
12.4.3 Financial Analysis
12.4.3.1 Net Revenue, 2018-2022
12.4.3.2 Regional Market Shares, 2022
12.4.4 Services Offered
12.4.5 Strategic Outlook
12.5 FedEx
12.5.1 Company Snapshot
12.5.2 Company Overview
12.5.3 Financial Analysis
12.5.3.1 Net Revenue, 2015-2022
12.5.3.2 Regional Market Shares, 2022
12.5.4 Product Benchmarking
12.5.5 Strategic Outlook
12.6 United Parcel Service, Inc.
12.6.1 Company Snapshot
12.6.2 Company Overview
12.6.3 Financial Analysis
12.6.3.1 Net Revenue, 2018-2022
12.6.4 Product Benchmarking
12.7 KERRY LOGISTICS NETWORK LIMITED
12.7.1 Company Snapshot
12.7.2 Company Overview
12.7.3 Financial Analysis
12.7.3.1 Net Revenue, 2017-2021
12.7.3.2 Regional Market Shares, 2022
12.7.4 Product Benchmarking
12.8 Kuehne+Nagel
12.8.1 Company Snapshot
12.8.2 Company Overview
12.8.3 Financial Analysis
12.8.3.1 Net Revenue, 2018-2022
12.8.3.2 Regional Market Shares, 2022
12.8.4 Product Benchmarking
12.8.5 Strategic Outlook
12.9 Bilcare Limited
12.9.1 Company Snapshot
12.9.2 Company Overview
12.9.3 Financial Analysis
12.9.3.1 Net Revenue, 2018-2022
12.9.3.2 Regional Market Shares, 2022
12.9.4 Product Benchmarking
12.10 Mayne Pharma Group Limited
12.10.1 Company Snapshot
12.10.2 Company Overview
12.10.3 Financial Analysis
12.10.3.1 Net Revenue, 2018-2022
12.10.3.2 Regional Market Shares, 2022
12.10.4 Product Benchmarking
12.10.5 Strategic Outlook
12.11 Intertek Group plc
12.11.1 Company Snapshot
12.11.2 Company Overview
12.11.3 Financial Analysis
12.11.3.1 Net Revenue, 2017-2021
12.11.4 Product Benchmarking
12.11.5 Strategic Outlook
12.12 Almac Group
12.12.1 Company Snapshot
12.12.2 Company Overview
12.12.3 Product Benchmarking
12.12.4 Strategic Outlook
12.13 Parexel International (MA) Corporation
12.13.1 Company Snapshot
12.13.2 Company Overview
12.13.3 Product Benchmarking
12.13.4 Strategic Outlook
12.14 Biocair
12.14.1 Company Snapshot
12.14.2 Company Overview
12.14.3 Product Benchmarking
12.14.4 Strategic Outlook
12.15 Marken (A UPS Company)
12.15.1 Company Snapshot
12.15.2 Company Overview
12.15.3 Product Benchmarking
12.15.4 Strategic Outlook
12.16 PCI Pharma Services (PCI)
12.16.1 Company Snapshot
12.16.2 Company Overview
12.16.3 Product Benchmarking
12.16.4 Strategic Outlook
12.17 Capsugel
12.17.1 Company Snapshot
12.17.2 Company Overview
12.17.3 Product Benchmarking
12.17.4 Strategic Outlook
12.18 Movianto
12.18.1 Company Snapshot
12.18.2 Company Overview
12.18.3 Product Benchmarking
12.19 Yourway
12.19.1 Company Snapshot
12.19.2 Company Overview
12.19.3 Product Benchmarking
13 Conclusion and Recommendations
13.1 Concluding Remarks from
13.2 Recommendations for Market Players

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings